111, Inc. Reports Strong Growth in Q2 2024 Financial Results

Strong Revenue Growth

111, Inc., a prominent tech-enabled healthcare platform company in China, has reported robust financial results for the second quarter of 2024. The company's net revenues soared to RMB 4.1 billion (US$566.3 million), marking a substantial 14.7% increase compared to the same period in 2023 1

1

. This growth demonstrates the company's continued expansion and market penetration in the Chinese healthcare sector.

Improved Profitability

One of the most notable aspects of 111, Inc.'s Q2 2024 results is the significant improvement in profitability. The company reported a non-GAAP net profit of RMB 5.5 million (US$0.8 million), a remarkable turnaround from the net loss of RMB 62.8 million in Q2 2023 2

2

. This achievement underscores the effectiveness of the company's strategic initiatives and operational efficiency improvements.

Segment Performance

The B2B segment, which includes the company's online medical platform, continued to be the primary driver of growth. B2B net revenues reached RMB 3.9 billion (US$542.5 million), representing a 14.8% year-over-year increase 1

1

. This segment's strong performance reflects the growing demand for 111, Inc.'s digital healthcare solutions among healthcare professionals and institutions.

Operational Highlights

111, Inc. reported several operational achievements during Q2 2024. The number of partnering stores in its digital pharmacy network expanded to over 600,000 2

2

. This extensive network enhances the company's ability to serve a broader customer base and strengthens its position in the market.

Management Commentary

Dr. Yu Gang, Co-Founder and Executive Chairman of 111, Inc., expressed satisfaction with the quarter's results, stating, "Our second quarter results demonstrate the strength of our business model and the success of our growth strategies" 1

1

. He emphasized the company's commitment to leveraging technology to improve healthcare accessibility and efficiency in China.

Future Outlook

Looking ahead, 111, Inc. remains optimistic about its growth prospects. The company plans to continue investing in its technology infrastructure, expanding its product offerings, and enhancing its digital capabilities to meet the evolving needs of the healthcare industry 2

2

. With the positive momentum from Q2 2024, 111, Inc. is well-positioned to capitalize on the growing demand for digital healthcare solutions in China.